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Sarcoidosis is a systemic disease characterized by the formation of non-caseating granulomas in mul-
tiple organs.  In the diagnosis of sarcoidosis,  imaging modalities such as ultrasonography,  computed 
tomography (CT) and magnetic resonance imaging (MRI) are useful; however,  there are few reports 
of MRI imaging using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB) MRI.  A 
46-year-old Japanese female with suspected pulmonary sarcoidosis was admitted to our hospital 
because low-density mottles in the liver were observed incidentally by chest CT.  The low-density 
mottles were not enhanced at the arterial phase or portal phase by abdominal CT and MRI,  and 
decreased uptake was observed in the hepatobiliary phase of Gd-EOB MRI.  No hematological disorder 
was observed except for a slight increase of biliary enzymes.  The lesion was diagnosed as liver sar-
coidosis by the liver biopsy.  Since the patient refused steroid therapy,  we prescribed ursodeoxycholic 
acid (UDCA).  600mg/day.  The serum levels of biliary enzymes were normalized and the abdominal 
CT ﬁndings gradually improved after the initiation of UDCA medication.  Gd-EOB MRI showed unique 
hypointense areas in the liver at the hepatobiliary phase,  which might be useful in the diagnosis of 
liver sarcoidosis.
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arcoidosis is a systemic disease characterized 
by the formation of non-caseating granulomas in 
multiple organs.  The exact cause of sarcoidosis is 
unknown.  Sarcoidosis generally aﬀects the hilar 
lymph nodes,  lungs,  and eyes [1]; most cases involve 
the enlargement of bilateral hilar lymph nodes and the 
development of lung lesions that are detectable by 
thoracic radiography.  Numerous asymptomatic cases 
are incidentally identiﬁed on examination,  whereas 
symptomatic cases are often concomitantly detected 
based on eye,  respiratory,  and skin symptoms.  
Observation without any treatment (i.e.,  “wait and 
see”) is used in most sarcoidosis cases,  but individuals 
with severe visual disorder and cardiac dysfunction 
are treated with steroids.
　 Here we report the incidental identiﬁcation of a 
liver lesion during a thoracic computed tomography 
(CT) examination of a lung sarcoidosis patient who was 
under observation.  Unique images were observed by 
gadolinium ethoxybenzyl diethylenetriamine pentaa-
cetic acid (Gd-EOB) MRI,  and treatment using oral 
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ursodeoxycholic acid (UDCA) resulted in improved 
blood test and imaging results.
Case Presentation
　A patient was a 46-year-old Japanese female.  Her 
medical history and family history revealed no 
remarkable information.  In June 2006,  she underwent 
an examination by thoracic radiography,  which 
detected granular shadows in her thorax; she was 
admitted to our hospital for further examination.  A 
chest X-ray suggested sarcoidosis,  and a bronchos-
copy was planned.  However,  the examination was 
terminated because of suspected xylocaine shock.  No 
signiﬁcant ﬁndings were observed by fundoscopy,  
echocardiography,  and abdominal CT.  We then 
decided to monitor the patient using periodic thoracic 
radiography and CT examinations at an outpatient 
clinic.
　 No subjective symptoms were found.  However,  in 
June 2010 an intrahepatic patchy pattern shadow 
emerged during a thoracic CT examination,  and she 
was therefore admitted again to our hospital for fur-
ther examination.  In the blood test at the time of 
admission,  her alkaline phosphatase (ALP) and 
gamma-glutamyl transpeptidase (γ-GTP) levels were 
410IU/L and 62IU/L,  respectively,  which suggested 
a mild increase in hepatobiliary enzymes.  However,  
her transaminase level was normal,  and her AST and 
ALT levels were 28IU/L and 19IU/L,  respectively.  
The angiotensin-converting enzyme (ACE) level was 
elevated to 35.3IU/L.  The hepatic tumor marker 
level was also normal; alpha-fetoprotein (AFP) was 
3.3ng/mL.
　 In a thoracic radiogram,  a nodular shadow was 
observed in the middle zone of the right lung.  No 
undisputable hilar lymph node enlargement was 
observed.  In abdominal ultrasonography,  a low echoic 
area was observed in the hepatic border which corre-
sponded to the map-like low-density area observed 
during the CT examination.  An intrahepatic diﬀuse 
map-like low-density area was also detected,  but no 
early- or late-contrast eﬀects were observed in 
abdominal dynamic CT examination (Fig.  1).  In addi-
tion,  the low-density area detected by CT appeared 
slightly hypointense on T1-weighted imaging,  and 
slightly hyperintense on T2-weighted imaging in 
abdominal Gd-EOB MRI (Fig.  2).
　 The intensity of the liver was lower than that of the 
spleen in T2-weighted imaging.  Similar to the CT 
results,  MRI did not show any contrast eﬀects.  In 
addition,  hepatobiliary-phase contrast MRI showed 
308 Acta Med.  Okayama　Vol.  69,  No.  5Wada et al.
A B
C D
Fig. 1　 Dynamic CT: The low-density mottles in the liver were observed at the precontrast phase (A),  and were not enhanced at the 
arterial phase (B),  portal phase (C) or delayed phase (D).
hypointense lesions.  The hypointense area on the 
hepatobiliary phase in Gd-EOB MRI was slightly 
larger than the low-density area in dynamic CT.
　 A liver biopsy was performed in June 2010 to 
establish a deﬁnitive diagnosis.  In the pathology 
investigation,  the lobular structure of the liver was 
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Fig. 2　 Gd-EOB MRI: The low intensity mottles were observed on a T1-weighted image (A),  and the high-intensity mottles were 
observed on a T2-weighted image (B).  The mottles were not enhanced at the arterial phase (C) or portal phase (D).  Decreased uptake 
was observed in the hepatobiliary phase (E).
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Fig. 3　 Histological ﬁndings of the liver needle biopsy (hematoxylin and eosin staining).  From the portal region to the liver parenchyma,  
multiplication of the epithelioid cells containing a multinuclear giant cell was observed. 
intact,  but multinucleated giant cells were detected in 
the portal area-peripheral liver parenchyma; multipli-
cation of epithelioid cells was observed (Fig.  3).  We 
made the diagnosis of liver sarcoidosis with the 
pathology ﬁndings.  Subjective symptoms were not 
found; however,  pathological changes in the liver and 
abnormal levels for biliary enzymes were observed,  
and thus steroid treatment was recommended.  The 
patient expressed a strong preference for taking oral 
medications,  and thus,  oral UDCA 600 mg/day was 
initiated.
　 After the introduction of UDCA,  a gradual 
improvement was observed in the patientʼs blood tests 
(Fig.  4).  Although an intrahepatic low-density area 
was constantly observed during abdominal CT imaging,  
the patient continued to show improvement.  After 1 
year and 7 months of treatment with UDCA,  the 
patient has not experienced any general health prob-
lems and has been given a good prognosis.
Discussion
　 Liver sarcoidosis accounts for approx.  20-30ｵ of 
all sarcoidosis cases.  In Japan,  approx.  40-60ｵ of 
sarcoidosis cases are detected during autopsy,  and the 
cases commonly involve the lungs,  lymph nodes,  and 
heart [2].  Most sarcoidosis cases,  including our 
patient,  are asymptomatic,  anorexia,  general malaise,  
and fever are also infrequently reported.  Rare sarcoi-
dosis cases may be associated with portal hyperten-
sion,  jaundice,  and liver cirrhosis because of vascular 
pressure attributable to a granuloma [3,  4].
　 Imaging ﬁndings for liver sarcoidosis generally 
involve multiple nodules; however,  a few cases,  
including our patient,  have shown diﬀuse map-like 
lesions.  The fusion of nodules has also been reported 
in some cases,  in which multiple nodular lesions com-
bine into a larger map-like lesion.  Hypoechoic nodules 
detected during abdominal ultrasonography have also 
been reported,  although some cases show internal 
coarse echo and hyperechoic nodules [5].  Low-
density areas may sometimes be observed in the 
aﬀected area during CT imaging without contrast 
eﬀect,  making it diﬃcult to diﬀerentiate between 
metastatic liver cancer and liver abscess [4,  6].  No 
patterns in T1- and T2-weighted MRI imaging have 
been established for liver sarcoidosis.  However,  
superparamagnetic iron oxide particle (SPIO) contrast 
reduces the intake of the lesion,  which results in a 
hyperintense image that may be useful for diagnosis.
　 In our patient,  CT imaging demonstrated a low-
density area,  whereas in her MRI examination,  
T2-weighted images showed hyperintense lesions and 
T1-weighted imaging showed hypointense lesions.  
These ﬁndings suggested an increase in cell density,  
which reﬂects an increase in the amount of water.  The 
decreased intensity of the liver on T2-weighted images 
was emphasized by comparing the intensity of the 
spleen.  A diﬀerence in intensity between the liver 
area and spleen was also reported by Chundru et al.  
[7],  and this ﬁnding might be ubiquitous in liver sar-
coidosis.  In our patient,  the intensity of liver sarcoi-
dosis was similarly lower than that of the spleen on 
T2-weighted images.  We speculate that the sarcoid 
nodules destroyed normal liver tissue,  and thus the 
blood ﬂow to the liver was reduced.  The reduction in 
blood ﬂow in the sarcoid nodules might thus have 
aﬀected the contrast of the sarcoid lesion and the 
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Fig. 4　 The patientʼs clinical course. Her γ-GTP and ALP levels improved after UDCA treatment was initiated. 
spleen.
　 A reduction in blood ﬂow in the lesion has also 
inhibited the contrast eﬀect of imaging.  A reduction 
in the intake of the contrast dye,  which is attributable 
to the destruction of normal liver tissue,  resulted in 
the generation of hypointensity on the hepatobiliary 
phase.  In our patientʼs case,  we observed that the 
hypointense area on the hepatobiliary phase in 
Gd-EOB MRI was slightly larger than the low-density 
area in dynamic CT,  suggesting that the liver cell 
function was deteriorated without the reduction of 
blood ﬂow at the boundary of the lesion.  There are 
few reports showing the intake of Gd-EOB by hepato-
cytes,  which might shed light on the liver function of 
sarcoidosis.
　 In the absence of imaging results or in cases of 
undetectable impairment of liver function,  approx.  
80ｵ of liver sarcoidosis cases are diagnosed using 
laparoscopic liver biopsy [8].  A clinicopathological 
report of 100 cases of liver sarcoidosis [9] included 
ﬁndings such as cholestatic disorder,  a mix of chole-
static disorder and hepatocyte damage,  and hepatitis; 
all cases showed varying degrees of non-caseating 
granuloma,  as well as multinucleated giant cells and 
asteroid bodies.
　 In the present case,  UDCA was eﬀective.  The 
mechanism of action of UDCA involves immunoregula-
tion.  It was reported that UDCA modulates the action 
of nuclear glucocorticoid receptors [10-12],  thus 
suggesting that its eﬀect may be attributable to its 
steroid-like action.
Conclusion
　 Our patientʼs case involved sarcoidosis of the liver 
with unique Gd-EOB MRI ﬁndings and successful 
treatment with oral UDCA.
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